Pulmatrix Inc
General ticker "PULM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $22.3M
Pulmatrix Inc follows the US Stock Market performance with the rate: 25.0%.
Estimated limits based on current volatility of 3.4%: low 5.78$, high 6.19$
Factors to consider:
- Current price 59.0% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.46$, 3.62$]
- 2024-12-30 to 2025-12-30 estimated range: [1.51$, 3.59$]
Financial Metrics affecting the PULM estimates:
- Negative: Non-GAAP EPS, $ of -3.86 <= 0.10
- Negative: Operating profit margin, % of -66.88 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -69.27 <= 2.35
- Positive: -0.96 < Investing cash flow per share, $ of -0.19
Short-term PULM quotes
Long-term PULM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $5.17MM | $6.07MM | $7.30MM |
| Operating Expenses | $25.34MM | $25.02MM | $22.04MM |
| Operating Income | $-20.17MM | $-18.95MM | $-14.74MM |
| Non-Operating Income | $-0.00MM | $0.11MM | $0.62MM |
| R&D Expense | $15.38MM | $18.24MM | $15.52MM |
| Income(Loss) | $-20.17MM | $-18.84MM | $-14.12MM |
| Profit(Loss) | $-20.17MM | $-18.84MM | $-14.12MM |
| Stockholders Equity | $47.45MM | $31.11MM | $18.00MM |
| Inventory | $0.00MM | $0.15MM | $0.00MM |
| Assets | $58.82MM | $40.95MM | $33.96MM |
| Operating Cash Flow | $-19.73MM | $-19.36MM | $-15.98MM |
| Capital expenditure | $0.14MM | $0.09MM | $0.68MM |
| Investing Cash Flow | $-0.14MM | $-0.09MM | $-0.68MM |
| Financing Cash Flow | $43.48MM | $1.23MM | $0.05MM |
| Earnings Per Share* | $-8.31 | $-5.43 | $-3.87 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.